About IgG receptor FcRn large subunit p51
IgG receptor FcRn large subunit p51 (FCGRT) is a protein
from Homo sapiens identified by UniProt accession
P55899, 365 residues long.
MolForge cross-references it against 0 known binders and
248 disease associations.
Target properties
| Protein name | IgG receptor FcRn large subunit p51 |
| UniProt accession | P55899 |
| Gene | FCGRT |
| Organism | Homo sapiens |
| Length | 365 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (7)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (248)
Diseases linked to this target (Open Targets).
- serum albumin measurement · score 0.68
- total blood protein measurement · score 0.68
- calcium measurement · score 0.59
- Myasthenia gravis · score 0.57
- hemoglobin measurement · score 0.43
- erythrocyte count · score 0.40
- hematocrit · score 0.39
- autoimmune thrombocytopenic purpura · score 0.39
- immune system disease · score 0.37
- eye disease · score 0.37
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P55899-F1 | alphafold | PREDICTED | 84.99 | — |
Amino-acid sequence (365 residues)
MGVPRPQPWA LGLLLFLLPG SLGAESHLSL LYHLTAVSSP APGTPAFWVS GWLGPQQYLS YNSLRGEAEP CGAWVWENQV SWYWEKETTD LRIKEKLFLE AFKALGGKGP YTLQGLLGCE LGPDNTSVPT AKFALNGEEF MNFDLKQGTW GGDWPEALAI SQRWQQQDKA ANKELTFLLF SCPHRLREHL ERGRGNLEWK EPPSMRLKAR PSSPGFSVLT CSAFSFYPPE LQLRFLRNGL AAGTGQGDFG PNSDGSFHAS SSLTVKSGDE HHYCCIVQHA GLAQPLRVEL ESPAKSSVLV VGIVIGVLLL TAAAVGGALL WRRMRSGLPA PWISLRGDDT GVLLPTPGEA QDADLKDVNV IPATA
Explore IgG receptor FcRn large subunit p51 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets